These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2879210)

  • 21. The dawn phenomenon does not occur in normal elderly subjects.
    Meneilly GS; Elahi D; Minaker KL; Rowe JW
    J Clin Endocrinol Metab; 1986 Aug; 63(2):292-6. PubMed ID: 3522617
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lack of effect of hyperglycemia on lipolysis in humans.
    Caruso M; Divertie GD; Jensen MD; Miles JM
    Am J Physiol; 1990 Oct; 259(4 Pt 1):E542-7. PubMed ID: 1977322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resistance of growth hormone secretion to somatostatin in men with type I diabetes mellitus.
    Cohen RM; Abplanalp WA
    Diabetes; 1991 Oct; 40(10):1251-8. PubMed ID: 1682193
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advantageous metabolic effects of pulsatile insulin delivery in noninsulin-dependent diabetic patients.
    Paolisso G; Sgambato S; Gentile S; Memoli P; Giugliano D; Varricchio M; D'Onofrio F
    J Clin Endocrinol Metab; 1988 Nov; 67(5):1005-10. PubMed ID: 3053747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gastric inhibitory polypeptide in obesity and diabetes mellitus.
    Service FJ; Rizza RA; Westland RE; Hall LD; Gerich JE; Go VL
    J Clin Endocrinol Metab; 1984 Jun; 58(6):1133-40. PubMed ID: 6373812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The growth hormone releasing hormone (GHRH) response to a mixed meal is blunted in young adults with insulin-dependent diabetes mellitus whereas the somatostatin response is normal.
    Foot AB; Davidson K; Edge JA; Wass JA; Dunger DB
    Clin Endocrinol (Oxf); 1990 Feb; 32(2):177-83. PubMed ID: 1971774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of growth hormone on glucose-induced glucose uptake in normal men as assessed by the hyperglycemic clamp technique.
    Orskov L; Schmitz O; Jørgensen JO; Arnfred J; Abildgaard N; Christiansen JS; Alberti KG; Orskov H
    J Clin Endocrinol Metab; 1989 Feb; 68(2):276-82. PubMed ID: 2563732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic effects of graded glucagon infusions in man: inhibition of glucagon, insulin, and somatostatin response to arginine.
    Pontiroli AE; Perfetti MG; Andreotti AC; Fattor B; Monti LD; Pozza G
    Metabolism; 1993 Oct; 42(10):1242-8. PubMed ID: 8105365
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The insulin secretagogues glibenclamide and repaglinide do not influence growth hormone secretion in humans but stimulate glucagon secretion during profound insulin deficiency.
    Østergård T; Degn KB; Gall MA; Carr RD; Veldhuis JD; Thomsen MK; Rizza RA; Schmitz O
    J Clin Endocrinol Metab; 2004 Jan; 89(1):297-302. PubMed ID: 14715864
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pituitary and extrapituitary effects of somatostatin in normal man.
    Copinschi G; Leclercq-Meyer V; Virasoro E; L'Hermite M; Vanhaelst L; Golstein J; Leclercq R; Féry F; Robyn C
    Horm Metab Res; 1976 May; 8(3):226-31. PubMed ID: 181309
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The insulinotropic effect of acute exendin-4 administered to humans: comparison of nondiabetic state to type 2 diabetes.
    Egan JM; Clocquet AR; Elahi D
    J Clin Endocrinol Metab; 2002 Mar; 87(3):1282-90. PubMed ID: 11889200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impaired basal glucose effectiveness in NIDDM: contribution of defects in glucose disappearance and production, measured using an optimized minimal model independent protocol.
    Basu A; Caumo A; Bettini F; Gelisio A; Alzaid A; Cobelli C; Rizza RA
    Diabetes; 1997 Mar; 46(3):421-32. PubMed ID: 9032098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Somatostatin enhances insulin-mediated glucose disposal in elderly subjects.
    Meneilly GS; Elahi D; Minaker KL; Rowe JW
    J Clin Endocrinol Metab; 1988 Aug; 67(2):407-10. PubMed ID: 2899090
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Manipulation of substrate utilization with somatostatin in patients with secondary multiple organ dysfunction syndrome.
    Arnold J; Campbell IT; Hipkin LJ; Keegan M; Jenkins S; O'Sullivan E; Chadwick S
    Crit Care Med; 1995 Jan; 23(1):71-7. PubMed ID: 8001390
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of the new somatostatin analogue (BIM 23014) on blood glucose homeostasis in normal men.
    Kuhn JM; Basin C; Mollard M; De Rouge B; Schatz B; Wolf LM
    Eur J Clin Invest; 1992 Dec; 22(12):793-9. PubMed ID: 1478250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Semisynthetic human insulin and purified pork insulin do not differ in their biological potency.
    Arias P; Kerner W; Navascués I; Schäfauer G; Pfeiffer EF
    Klin Wochenschr; 1984 Dec; 62(24):1145-50. PubMed ID: 6397660
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of somatostatin on blood sugar, plasma growth hormone, and glucagon levels in diabetic children.
    Del Guercio MJ; di Natale B; Gargantini L; Garlaschi C; Chiumello G
    Diabetes; 1976 Jul; 25(7):550-3. PubMed ID: 1278605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of Calcitonin on plasma glucose, C-peptide, glucagon and growth hormone responses to arginine in insulin-dependent diabetic subjects.
    Sgambato S; Passariello N; Giugliano D; Torella R; D'Onofrio F
    Acta Diabetol Lat; 1981; 18(3):235-41. PubMed ID: 7029989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early-morning hyperglycemia in IDDM. Acute effects of cholinergic blockade.
    Atiea JA; Creagh F; Page M; Owens DR; Scanlon MF; Peters JR
    Diabetes Care; 1989; 12(7):443-8. PubMed ID: 2667925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma growth hormone, somatostatin, insulin and glucagon inter-relationships during infusion of human pancreatic growth hormone-releasing factor in young and adult ducks (Anas platyrhynchos).
    Foltzer-Jourdainne C; Harvey S; Karmann H; Mialhe P
    J Endocrinol; 1987 Jul; 114(1):25-32. PubMed ID: 2888829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.